B cell M-CLL clones retain selection against replacement mutations in their immunoglobulin gene framework regions

Hadas Neuman1, Jessica Arrouasse1, Ohad Benjamini2,3

  • 1The Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel.

Frontiers in Oncology
|April 3, 2023
PubMed

Insights

Chronic lymphocytic leukemia (CLL) exhibits altered B cell clone dynamics due to weakened selection forces on mutations. Non-dominant B cells in CLL patients also show distinct mutation patterns compared to healthy individuals.

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia.
  • Understanding B-lymphocyte clone dynamics in CLL is crucial for disease management.

Purpose of the Study:

  • To investigate somatic hypermutation (SHM) and selection in CLL B-cell clones using lineage tree analysis.
  • To compare dominant (malignant) CLL clones with non-dominant (normal) B cells within patients and with healthy controls.

Main Methods:

  • Lineage tree-based analysis of SHM and selection.
  • Comparison of dominant CLL clones, non-dominant B cells from CLL patients, and B cells from healthy controls.
  • Machine learning to identify distinct mutational features.

Main Results:

  • CLL dominant clones accumulate more replacement mutations affecting amino acid properties.
  • CLL clones show weaker selection for/against mutations in complementarity determining regions (CDRs) and framework regions (FWRs) compared to controls.
  • Non-dominant CLL B cells exhibit higher transition mutation fractions than healthy controls.

Conclusions:

  • CLL is associated with a relaxation, not complete loss, of selection forces on B cell clones.
  • Altered SHM mechanisms may also contribute to CLL pathogenesis.
  • Distinct mutational profiles in non-dominant B cells suggest broader B-cell dysregulation in CLL.
Abstract

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
1.1K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.3K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
2.1K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
692
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
945